ATON
Price
$6.49
Change
-$0.32 (-4.70%)
Updated
Sep 8, 02:24 PM (EDT)
Capitalization
11.6M
NBY
Price
$2.72
Change
-$1.01 (-27.08%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
21.72M
Interact to see
Advertisement

ATON vs NBY

Header iconATON vs NBY Comparison
Open Charts ATON vs NBYBanner chart's image
AlphaTON Capital
Price$6.49
Change-$0.32 (-4.70%)
Volume$614
Capitalization11.6M
NovaBay Pharmaceuticals
Price$2.72
Change-$1.01 (-27.08%)
Volume$48.2K
Capitalization21.72M
ATON vs NBY Comparison Chart in %
Loading...
ATON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATON vs. NBY commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATON is a StrongBuy and NBY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (ATON: $5.09 vs. NBY: $3.73)
Brand notoriety: ATON and NBY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATON: 69% vs. NBY: 105%
Market capitalization -- ATON: $11.6M vs. NBY: $21.72M
ATON [@Biotechnology] is valued at $11.6M. NBY’s [@Biotechnology] market capitalization is $21.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATON’s FA Score shows that 0 FA rating(s) are green whileNBY’s FA Score has 2 green FA rating(s).

  • ATON’s FA Score: 0 green, 5 red.
  • NBY’s FA Score: 2 green, 3 red.
According to our system of comparison, NBY is a better buy in the long-term than ATON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATON’s TA Score shows that 6 TA indicator(s) are bullish while NBY’s TA Score has 5 bullish TA indicator(s).

  • ATON’s TA Score: 6 bullish, 4 bearish.
  • NBY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ATON is a better buy in the short-term than NBY.

Price Growth

ATON (@Biotechnology) experienced а -29.31% price change this week, while NBY (@Biotechnology) price change was +109.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +11.00%, and the average quarterly price growth was +33.00%.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBY($21.7M) has a higher market cap than ATON($11.6M). NBY YTD gains are higher at: 520.632 vs. ATON (-1.547). ATON (-6.74M) and NBY (-7.05M) have comparable annual earnings (EBITDA) . NBY has higher revenues than ATON: NBY (9.78M) vs ATON (0).
ATONNBYATON / NBY
Capitalization11.6M21.7M53%
EBITDA-6.74M-7.05M96%
Gain YTD-1.547520.632-0%
P/E RatioN/A1.62-
Revenue09.78M-
Total CashN/A5.34M-
Total DebtN/A1.04M-
FUNDAMENTALS RATINGS
ATON vs NBY: Fundamental Ratings
ATON
NBY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10012
PRICE GROWTH RATING
1..100
6534
P/E GROWTH RATING
1..100
891
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBY's Valuation (45) in the Biotechnology industry is in the same range as ATON (59) in the null industry. This means that NBY’s stock grew similarly to ATON’s over the last 12 months.

NBY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATON (100) in the null industry. This means that NBY’s stock grew similarly to ATON’s over the last 12 months.

NBY's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for ATON (100) in the null industry. This means that NBY’s stock grew significantly faster than ATON’s over the last 12 months.

NBY's Price Growth Rating (34) in the Biotechnology industry is in the same range as ATON (65) in the null industry. This means that NBY’s stock grew similarly to ATON’s over the last 12 months.

NBY's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for ATON (89) in the null industry. This means that NBY’s stock grew significantly faster than ATON’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATONNBY
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 18 days ago
86%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAZE15.880.84
+5.59%
Maze Therapeutics Inc
TYL559.965.73
+1.03%
Tyler Technologies
FNWD32.630.28
+0.87%
Finward Bancorp
MBRX0.38N/A
-1.06%
Moleculin Biotech
CIVI34.39-1.08
-3.04%
Civitas Resources

ATON and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATON has been loosely correlated with AMGXF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ATON jumps, then AMGXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATON
1D Price
Change %
ATON100%
-6.61%
AMGXF - ATON
34%
Loosely correlated
N/A
NBY - ATON
34%
Loosely correlated
-11.61%
DYAI - ATON
29%
Poorly correlated
-4.90%
CORT - ATON
29%
Poorly correlated
-0.01%
PRLD - ATON
27%
Poorly correlated
+7.89%
More

NBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBY has been loosely correlated with THAR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NBY jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBY
1D Price
Change %
NBY100%
-11.61%
THAR - NBY
45%
Loosely correlated
-7.77%
NEVPF - NBY
41%
Loosely correlated
N/A
ATON - NBY
38%
Loosely correlated
-6.61%
ALT - NBY
30%
Poorly correlated
+6.18%
ORMP - NBY
29%
Poorly correlated
+0.45%
More